- Home
- ALZN vs POLA Comparison
ALZN vs POLA Comparison
Compare ALZN & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- POLA
- Stock Information
- Founded
- ALZN 2016
- POLA 1979
- Country
- ALZN United States
- POLA United States
- Employees
- ALZN N/A
- POLA N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- POLA Industrial Machinery/Components
- Sector
- ALZN Health Care
- POLA Miscellaneous
- Exchange
- ALZN Nasdaq
- POLA Nasdaq
- Market Cap
- ALZN 8.2M
- POLA 8.7M
- IPO Year
- ALZN 2021
- POLA 2016
- Fundamental
- Price
- ALZN $2.53
- POLA $4.87
- Analyst Decision
- ALZN Strong Buy
- POLA
- Analyst Count
- ALZN 1
- POLA 0
- Target Price
- ALZN $42.00
- POLA N/A
- AVG Volume (30 Days)
- ALZN 170.2K
- POLA 55.5K
- Earning Date
- ALZN 09-10-2025
- POLA 11-13-2025
- Dividend Yield
- ALZN N/A
- POLA N/A
- EPS Growth
- ALZN N/A
- POLA N/A
- EPS
- ALZN N/A
- POLA N/A
- Revenue
- ALZN N/A
- POLA $11,967,000.00
- Revenue This Year
- ALZN N/A
- POLA N/A
- Revenue Next Year
- ALZN N/A
- POLA N/A
- P/E Ratio
- ALZN N/A
- POLA N/A
- Revenue Growth
- ALZN N/A
- POLA 0.14
- 52 Week Low
- ALZN $2.06
- POLA $1.53
- 52 Week High
- ALZN $17.10
- POLA $5.59
- Technical
- Relative Strength Index (RSI)
- ALZN 52.36
- POLA 70.96
- Support Level
- ALZN $2.33
- POLA $3.20
- Resistance Level
- ALZN $2.55
- POLA $5.59
- Average True Range (ATR)
- ALZN 0.10
- POLA 0.46
- MACD
- ALZN 0.02
- POLA 0.12
- Stochastic Oscillator
- ALZN 66.07
- POLA 63.05
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.